Hualan Biological Engineering Inc.
002007
Classement en actions
#4385
Hualan Biological Engineering Inc. operates as a biopharmaceutical company,... Hualan Biological Engineering Inc. operates as a biopharmaceutical company, specializing in the research, development, production, and commercialization of a diverse portfolio of medical products within the People's Republic of China. Its offerings span plasma-derived therapies, various viral and bacterial vaccines, recombinant proteins, and other advanced biologics. The company's extensive range of plasma products includes essential components like human albumin, a broad spectrum of human immunoglobulins (such as intravenous, rabies, hepatitis B, and tetanus formulations), and vital coagulation factors like human prothrombin complex and factor VIII. Hualan also provides specialized solutions such as lyophilized human thrombin for external use and surgical fibrin glue. In its vaccine division, Hualan offers critical immunizations, including several influenza vaccines (e.g., split virus, A H1N1, and quadrivalent forms), recombinant hepatitis B vaccine, and ACYW135 meningococcal polysaccharide vaccine. The company actively pursues strategic collaborations with key scientific organizations, most notably the Chinese Academy of Sciences, as well as other esteemed research institutes and enterprises. Established in 1992, Hualan Biological Engineering Inc. is headquartered in Xinxiang, People's Republic of China.
Prix de l'action
$1.92
Capitalisation boursière
$3.50B
Changement (1 jour)
-1.39%
Changement (1 an)
-19.45%
Pays
CN
Échange Hualan Biological Engineering Inc. (002007)
Catégorie
Healthcare
Historique des dividendes pour Hualan Biological Engineering Inc. (002007)
Hualan Biological Engineering Inc. (symbole boursier : 002007) a versé un total de 22 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $4.00
Rendement du dividende (TTM) : 0.0781
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : $4.00
Rendement du dividende (TTM) : 0.0781
Versements de dividendes pour Hualan Biological Engineering Inc. (002007) de 2005 à 2026
Versements annuels de dividendes
| Année | Dividende (ajusté pour divisions d’actions) | Changez |
|---|---|---|
| 2026 (TTM) | $0.5 | -28.57% |
| 2025 | $0.7 | 133.33% |
| 2024 | $0.3 | 0.00% |
| 2023 | $0.3 | 50.00% |
| 2022 | $0.2 | -33.33% |
| 2021 | $0.3 | -25.00% |
| 2020 | $0.4 | 95.03% |
| 2019 | $0.2051 | 33.27% |
| 2018 | $0.1539 | -24.96% |
| 2017 | $0.2051 | 59.98% |
| 2016 | $0.1282 | -33.33% |
| 2015 | $0.1923 | 50.00% |
| 2014 | $0.1282 | 299.38% |
| 2013 | $0.0321 | -16.62% |
| 2012 | $0.0385 | -59.98% |
| 2011 | $0.0962 | 155.85% |
| 2010 | $0.0376 | 50.40% |
| 2009 | $0.025 | 19.62% |
| 2007 | $0.0209 | 15.47% |
| 2006 | $0.0181 | 24.83% |
| 2005 | $0.0145 | 0.00% |
Liste de tous les paiements de dividendes
| Année | Dividende | Changez |
|---|---|---|
| 2026 (TTM) | $0.5 | -28.57% |
| 2025 | $0.7 | 133.33% |
| 2024 | $0.3 | 0.00% |
| 2023 | $0.3 | 50.00% |
| 2022 | $0.2 | -33.33% |
| 2021 | $0.3 | -25.00% |
| 2020 | $0.4 | 95.03% |
| 2019 | $0.2051 | -31.63% |
| 2018 | $0.3 | -25.00% |
| 2017 | $0.4 | 0.00% |
| 2016 | $0.4 | -33.33% |
| 2015 | $0.6 | 50.00% |
| 2014 | $0.4 | 300.00% |
| 2013 | $0.1 | -16.67% |
| 2012 | $0.12 | -60.00% |
| 2011 | $0.3 | 60.00% |
| 2010 | $0.1875 | -6.25% |
| 2009 | $0.2 | 0.00% |
| 2007 | $0.2 | -36.00% |
| 2006 | $0.3125 | -16.67% |
| 2005 | $0.375 | 0.00% |
Dividendes versés par des entreprises similaires ou concurrentes
| Entreprise | Nombre de paiements de dividendes | Pays |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
